Antares pharma stock news

Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Antares Pharma Inc ATRS - Quotes, Financials, News, Charts ... About Antares Pharma Inc Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products

Antares Pharma, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Antares Pharma - ATRS - Stock Price & News | The Motley Fool Industry, sector and description for Antares Pharma. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable Antares Pharma, Inc. (ATRS) News Headlines - NASDAQ.com Antares Pharma, Inc. (ATRS) News – Find the latest company news headlines for Antares Pharma, Inc. and all the companies you research at NASDAQ.com

Get breaking news and analysis on Antares Pharma, Inc. (ATRS) stock, price quote and chart, trading and investing tools.

Antares Pharma, Inc. (ATRS): Price and ... - Stock News ATRS Stock Summary. With a year-over-year growth in debt of 87.4%, Antares Pharma Inc's debt growth rate surpasses 84.66% of about US stocks. Over the past twelve months, ATRS has reported earnings growth of -139.64%, putting it ahead of merely 10.44% of US stocks in our set. ATRS - Antares Pharma News - Barchart.com Latest news headlines for Antares Pharma with market analysis and analyst commentary. Antares Pharma (ATRS) Antares Pharma (ATRS) [[ item.lastPrice ]] Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. ATRS:NASDAQ CM Stock Quote - Antares Pharma Inc ...

Analyzing Antares Pharma (NASDAQ:ATRS) stock? View ATRS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at  

Antares Pharma, Inc. (ATRS) Stock Analysis & News ... Get breaking news and analysis on Antares Pharma, Inc. (ATRS) stock, price quote and chart, trading and investing tools. ATRS Stock Price, Forecast & News (Antares Pharma) 2 brokerages have issued 12 month price targets for Antares Pharma's stock. Their forecasts range from $5.00 to $6.00. On average, they anticipate Antares Pharma's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 172.3% from the stock's current price. View analysts' price targets for Antares Pharma. Antares Pharma - ATRS - Stock Price & News | The Motley Fool Real time Antares Pharma (ATRS) stock price quote, stock graph, The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. News & Analysis

Antares Pharma, Inc. (ATRS) Quote Overview » News » Antares Pharma, Inc. (ATRS) Zacks News Zacks News AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study

Antares Pharma Stock Price Forecast, ATRS stock price prediction. The best long -term & short-term Antares Pharma share price prognosis for 2020, 2021, 2022,  For Investors Antares Pharma: Making Medicines Feel Better. Recent News Antares Pharma, Inc. is not obligated to update the press releases and information  Antares Pharma Inc. Dividend Stock News and Updates. Aug. 07, 2019CLOSE PRICE INCREASE: Antares Pharma Inc. (NASDAQ: ATRS) on 08-07-2019  5 Mar 2020 The forecasts give the Antares Pharma Inc. stock a consensus price target representing an upside potential 47.52. Earnings Forecast. Analysts  (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and  2 Mar 2020 According to stock market daily analyst this is Lower then same time previous year.Antares Pharma Inc ,reported EPS for the same quarter last 

Antares Pharma Inc ATRS - Quotes, Financials, News, Charts ...

Real-time trade and investing ideas on Antares Pharma Inc. ATRS from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ATRS News Today (Antares Pharma) | MarketBeat What's going on at Antares Pharma (NASDAQ:ATRS)? View breaking news headlines for ATRS stock from trusted media outlets at MarketBeat. What's going on at Antares Pharma (NASDAQ:ATRS)? View breaking news headlines for ATRS stock from trusted media outlets at MarketBeat. S&P 500 2,626.65 (+3.35%) Antares Pharma, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Antares Pharma - ATRS - Stock Price & News | The Motley Fool Industry, sector and description for Antares Pharma. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable

2 brokerages have issued 12 month price targets for Antares Pharma's stock. Their forecasts range from $5.00 to $6.00. On average, they anticipate Antares Pharma's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 172.3% from the stock's current price. View analysts' price targets for Antares Pharma. Antares Pharma - ATRS - Stock Price & News | The Motley Fool Real time Antares Pharma (ATRS) stock price quote, stock graph, The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. News & Analysis ATRS | Antares Pharma Inc. Stock Price & News - WSJ